Pediatric Lupus Nephritis

A tétel rövid nézete
dc.contributor.advisorSzabó, Tamás
dc.contributor.advisordeptDebreceni Egyetem::Általános Orvostudományi Kar::Gyermekgyógyászati Intézethu_HU
dc.contributor.authorHelgason, Páll
dc.contributor.departmentDE--Általános Orvostudományi Karhu_HU
dc.contributor.opponentKaposzta, Rita
dc.contributor.opponentBalla, Jozsef
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Gyermekgyógyászati Intézethu_HU
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Belgyógyászati Intézethu_HU
dc.date.accessioned2018-01-02T13:38:19Z
dc.date.available2018-01-02T13:38:19Z
dc.date.created2017-10-19
dc.description.abstractSystemic lupus erythematosus (SLE) is an autoimmune disease that has multiple characteristic symptoms affecting almost every organ system in the body. Pediatric-onset SLE accounts for 10-20% of all SLE cases, with the age of disease occurring most frequently between the ages of 12 and 16 years. Clinical features and specific laboratory data are needed to diagnose LN. Once LN has accurately been identified, a renal biopsy must be performed to further classify the extent of LN. The classification can help to estimate the prognosis of disease, as well as give incite to the individualized treatment options. Most therapies of LN include a strong induction dosage of steroids and immunosuppressants at the onset of disease, and continuous maintenance therapy through the patient’s lifetime.hu_HU
dc.description.courseáltalános orvoshu_HU
dc.description.courselangangolhu_HU
dc.description.degreeegységes, osztatlanhu_HU
dc.format.extent33hu_HU
dc.identifier.urihttp://hdl.handle.net/2437/246745
dc.language.isoenhu_HU
dc.subjectpediatric lupus nephritishu_HU
dc.subjecttreatmenthu_HU
dc.subjectclinical manifestationhu_HU
dc.subjectDiagnosishu_HU
dc.subject.dspaceDEENK Témalista::Orvostudomány::Gyermekgyógyászathu_HU
dc.titlePediatric Lupus Nephritishu_HU
Fájlok
Gyűjtemények
Theses (Faculty of Medicine)